Stock KG KING PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News King Pharmaceuticals, Inc.

Equities

KG

US4955821081

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for King Pharmaceuticals, Inc.
2009 KING PHARMA : Burger King profit rises, shares jump RE
2009 KING PHARMA : Burger King augmente ses bénéfices au 4e trimestre RE

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
KING PHARMA : King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® Tablets
PR
KING PHARMA : The Law Office of Abe Shainberg is Launching an Investigation into the Possible Breaches of Fiduciary Duty by the Board of King Pharmaceuticals, Inc. in Connection with the Sale of the Company to Pfizer, Inc. – KG
BU
KING PHARMA : Law Office of Brodsky & Smith, LLC Announces Investigation of King Pharmaceuticals
BU
KING PHARMA : Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of King Pharmaceuticals, Inc.
BU
KING PHARMA : Ryan & Maniskas, LLP Announces Investigation of King Pharmaceuticals Inc.
BU
KING PHARMA : The Law Office of Robbins Umeda LLP Announces an Investigation of the Acquisition of King Pharmaceuticals, Inc. by Pfizer, Inc.
BU
KING PHARMA : King Pharmaceuticals Buyout Investigated for Shareholders by Goldfarb Branham Law Firm LLP
BU
KING PHARMA : The Briscoe Law Firm Investigates King Pharmaceuticals, Inc. for Shareholders Concerning the Buy-Out by Pfizer Inc.
BU
KING PHARMA : The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of King Pharmaceuticals, Inc. in Connection with the Sale of the Company to Pfizer, Inc. – NYSE:KG
BU
KING PHARMA : Kendall Law Group Investigates King Pharmaceuticals, Inc. Acquisition for Shareholders
BU
KING PHARMA : Pfizer to Acquire King Pharmaceuticals, Inc.
PR
KING PHARMA : Acura Pharmaceuticals and King Pharmaceuticals Provide Update on FDA Advisory Committee Meeting For Acurox(R)
PR
KING PHARMA : DURECT Corporation Announces Commencement of Phase IIb ELADUR(TM) (TRANSDUR(TM)-Bupivacaine) Clinical Trial by King Pharmaceuticals
PR
KING PHARMA : King Launches PainBalance(R): Educational Initiative to Help Reduce the Burden of Pain
PR
KING PHARMA : DURECT Signs Long Term Excipient Supply Agreement With King Pharmaceuticals for REMOXY(R)
PR
KING PHARMA : Burger King profit rises, shares jump
RE
KING PHARMA : Burger King augmente ses bénéfices au 4e trimestre
RE
KING PHARMA : Burger King profit rises
RE
KING PHARMA : Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain
PR
KING PHARMA : King Provides Additional Information on the REMOXY(R) NDA Resubmission Plan
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KG Stock
  4. News King Pharmaceuticals, Inc.